131.75
price up icon0.05%   0.06
after-market Dopo l'orario di chiusura: 131.78 0.03 +0.02%
loading
Precedente Chiudi:
$131.69
Aprire:
$131.75
Volume 24 ore:
1.01M
Relative Volume:
0.37
Capitalizzazione di mercato:
$14.03B
Reddito:
$612.78M
Utile/perdita netta:
$-86.37M
Rapporto P/E:
-151.44
EPS:
-0.87
Flusso di cassa netto:
$-62.91M
1 W Prestazione:
+0.11%
1M Prestazione:
+2.73%
6M Prestazione:
+79.74%
1 anno Prestazione:
+88.97%
Intervallo 1D:
Value
$131.71
$131.79
Intervallo di 1 settimana:
Value
$131.51
$131.79
Portata 52W:
Value
$64.09
$131.79

Intra Cellular Therapies Inc Stock (ITCI) Company Profile

Name
Nome
Intra Cellular Therapies Inc
Name
Telefono
(646) 440-9333
Name
Indirizzo
135 ROUTE 202/206, BEDMINSTER, NY
Name
Dipendente
860
Name
Cinguettio
Name
Prossima data di guadagno
2024-10-30
Name
Ultimi documenti SEC
Name
ITCI's Discussions on Twitter

Confronta ITCI con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
ITCI
Intra Cellular Therapies Inc
131.75 14.03B 612.78M -86.37M -62.91M -0.87
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
165.02 73.07B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.14 47.43B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.12 45.72B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
15.49 17.75B 16.54B -1.64B 749.00M -1.45

Intra Cellular Therapies Inc Stock (ITCI) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-24 Downgrade Mizuho Outperform → Neutral
2025-01-31 Downgrade Canaccord Genuity Buy → Hold
2024-09-06 Aggiornamento Piper Sandler Neutral → Overweight
2024-01-03 Iniziato Robert W. Baird Outperform
2023-12-11 Iniziato TD Cowen Outperform
2023-04-20 Iniziato Morgan Stanley Overweight
2022-08-22 Downgrade Goldman Buy → Neutral
2022-07-07 Iniziato Mizuho Buy
2022-06-14 Iniziato UBS Buy
2022-04-22 Iniziato Piper Sandler Neutral
2022-02-16 Iniziato Goldman Buy
2021-09-23 Iniziato Needham Buy
2020-12-15 Iniziato BofA Securities Buy
2020-12-10 Iniziato Goldman Buy
2020-02-20 Iniziato Evercore ISI Outperform
2020-01-31 Downgrade JP Morgan Overweight → Neutral
2019-12-24 Reiterato Canaccord Genuity Buy
2019-08-12 Iniziato Jefferies Buy
2018-02-26 Iniziato JP Morgan Overweight
2018-02-08 Iniziato RBC Capital Mkts Outperform
2017-12-15 Iniziato Canaccord Genuity Buy
2017-11-08 Aggiornamento SunTrust Hold → Buy
2017-09-07 Aggiornamento Piper Jaffray Neutral → Overweight
2017-08-30 Aggiornamento Ladenburg Thalmann Neutral → Buy
2017-08-24 Aggiornamento JMP Securities Mkt Perform → Mkt Outperform
2017-08-23 Aggiornamento Leerink Partners Mkt Perform → Outperform
2017-05-02 Downgrade Ladenburg Thalmann Buy → Neutral
2017-05-02 Downgrade Leerink Partners Outperform → Mkt Perform
2017-05-01 Downgrade Piper Jaffray Overweight → Neutral
2016-12-16 Iniziato Cantor Fitzgerald Overweight
2016-09-29 Reiterato RBC Capital Mkts Outperform
2016-09-29 Downgrade SunTrust Buy → Neutral
Mostra tutto

Intra Cellular Therapies Inc Borsa (ITCI) Ultime notizie

pulisher
Mar 27, 2025

Intra-Cellular Therapies Shareholders Approve Johnson & Johnson Merger - Investing.com

Mar 27, 2025
pulisher
Mar 27, 2025

Intra-Cellular Therapies: These Are 5 Critical Challenges Threatening Its Expansion Plans! - Smartkarma

Mar 27, 2025
pulisher
Mar 19, 2025

Intra-Cellular Therapies announces proxy statement supplement By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 18, 2025

Intra-Cellular Therapies announces proxy statement supplement - Investing.com

Mar 18, 2025
pulisher
Mar 18, 2025

Intra-Cellular Therapies stockholder filed lawsuit against co, board in NY Supreme Court - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

Intra-Cellular Therapies Stock Hits All-Time High of $131.47 By Investing.com - Investing.com UK

Mar 18, 2025
pulisher
Mar 18, 2025

Intra-Cellular Therapies (ITCI): Among the Best Biotech Stocks to Buy According to Billionaires - Yahoo Finance

Mar 18, 2025
pulisher
Mar 14, 2025

US Bancorp DE Sells 4,330 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - Defense World

Mar 14, 2025
pulisher
Mar 12, 2025

Scrip M&A Podcast: Looking At M&A Activity As Q1 Nears A Close - Scrip

Mar 12, 2025
pulisher
Mar 12, 2025

Intra-Cellular Therapies (NASDAQ:ITCI) Now Covered by StockNews.com - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

Intra-Cellular Therapies Stock Hits All-Time High of $131.37 By Investing.com - Investing.com Australia

Mar 11, 2025
pulisher
Mar 11, 2025

Intra-Cellular Therapies Stock Hits All-Time High of $131.37 - Investing.com

Mar 11, 2025
pulisher
Mar 11, 2025

Jones Financial Companies Lllp Acquires 2,750 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - Defense World

Mar 11, 2025
pulisher
Mar 11, 2025

Charles Schwab Investment Management Inc. Increases Position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - Defense World

Mar 11, 2025
pulisher
Mar 11, 2025

Long Term Trading Analysis for (ITCI) - Stock Traders Daily

Mar 11, 2025
pulisher
Mar 09, 2025

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Shares Purchased by Bank of New York Mellon Corp - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Lisanti Capital Growth LLC Increases Stock Holdings in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat

Mar 08, 2025
pulisher
Mar 07, 2025

Intra-Cellular deal, Axsome settlement drive neurological index recovery - BioWorld Online

Mar 07, 2025
pulisher
Mar 07, 2025

Intra-Cellular Therapies, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 06, 2025

J&J to stop studies of depression drug due to low effectiveness - Reuters.com

Mar 06, 2025
pulisher
Mar 05, 2025

Johnson & Johnson: No More Tears, Just Gains In Intra-Cellular Acquisition - Seeking Alpha

Mar 05, 2025
pulisher
Mar 05, 2025

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Receives Average Recommendation of “Hold” from Brokerages - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

Intra-Cellular Therapies (NASDAQ:ITCI) Coverage Initiated at StockNews.com - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

Intra-Cellular Therapies progresses in Johnson & Johnson merger By Investing.com - Investing.com Canada

Mar 03, 2025
pulisher
Mar 03, 2025

Intra-Cellular Therapies progresses in Johnson & Johnson merger - Investing.com

Mar 03, 2025
pulisher
Mar 01, 2025

Intra-Cellular Therapies, Inc. (ITCI): Among the Best Psychedelic Stocks to Buy in 2025 - Yahoo Canada Finance

Mar 01, 2025
pulisher
Mar 01, 2025

GW&K Investment Management LLC Sells 6,734 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Phocas Financial Corp. Has $241,000 Position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Equities Analysts Offer Predictions for ITCI FY2025 Earnings - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

12 Best Psychedelic Stocks to Buy in 2025 - Insider Monkey

Feb 28, 2025
pulisher
Feb 28, 2025

Intra-Cellular Therapies (NASDAQ:ITCI) Reaches New 12-Month HighStill a Buy? - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Intra-Cellular Therapies Stock Soars to All-Time High of $128.01 - MSN

Feb 28, 2025
pulisher
Feb 28, 2025

Where are the Opportunities in (ITCI) - Stock Traders Daily

Feb 28, 2025
pulisher
Feb 28, 2025

Wealthspire Advisors LLC Acquires New Position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

ING Groep NV Purchases Shares of 12,500 Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Intra-Cellular Therapies (NASDAQ:ITCI) Stock Rating Lowered by Mizuho - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

HealthInvest Partners AB Sells 13,440 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Shares Purchased by Ieq Capital LLC - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

New York State Common Retirement Fund Has $6.40 Million Holdings in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat

Feb 27, 2025
pulisher
Feb 26, 2025

Intra-Cellular Therapies Stock Hits All-Time High of $129 By Investing.com - Investing.com Australia

Feb 26, 2025
pulisher
Feb 26, 2025

Intra-Cellular Therapies Stock Hits All-Time High of $129 - Investing.com

Feb 26, 2025
pulisher
Feb 25, 2025

INTRA-CELLULAR THERAPIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intra-Cellular Therapies, Inc.ITCI - Business Wire

Feb 25, 2025
pulisher
Feb 25, 2025

ITCI Q4 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales - MSN

Feb 25, 2025
pulisher
Feb 24, 2025

ITCI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intra-cellular Therapies, Inc. Is Fair to Shareholders - The Bakersfield Californian

Feb 24, 2025
pulisher
Feb 24, 2025

Intra-Cellular Therapies Reports Strong 2024 Growth - TipRanks

Feb 24, 2025
pulisher
Feb 24, 2025

This Conagra Brands Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Benzinga

Feb 24, 2025
pulisher
Feb 24, 2025

Mizuho cuts Intra-Cellular stock rating, lowers price target - Investing.com India

Feb 24, 2025
pulisher
Feb 24, 2025

Mizuho Downgrades Intra-Cellular Therapies to Neutral From Outperform, Lowers Price Target to $132 From $140 - Marketscreener.com

Feb 24, 2025
pulisher
Feb 24, 2025

StockNews.com Initiates Coverage on Intra-Cellular Therapies (NASDAQ:ITCI) - Defense World

Feb 24, 2025
pulisher
Feb 23, 2025

Intra-Cellular Therapies (NASDAQ:ITCI) Sets New 52-Week HighWhat's Next? - MarketBeat

Feb 23, 2025
pulisher
Feb 22, 2025

Allspring Global Investments Holdings LLC Raises Stake in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - Defense World

Feb 22, 2025

Intra Cellular Therapies Inc Azioni (ITCI) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$114.00
price down icon 0.39%
$8.84
price down icon 1.34%
$15.49
price down icon 1.27%
$97.04
price down icon 1.41%
$33.53
price down icon 0.47%
Capitalizzazione:     |  Volume (24 ore):